Additionally, by analyzing plasma proteomic data, levels of glial fibrillary acidic protein (GFAP) were identified as predictors of dementia up to 15 years before onset, showcasing the profound potential of proteomics in pre-emptive disease risk assessment [132]. Here, GFAP is linked to dementia.